Correspondence 0001213900-24-079033 from Haoxi Health Technology Ltd (HAO)
Haoxi Health Technology Ltd
Date: Sept. 16, 2024 · CIK: 0001954594 · Accession: 0001213900-24-079033
AI Filing Summary & Sentiment
File numbers found in text: 333-280174
Show Raw Text
CORRESP
1
filename1.htm
September 16, 2024
VIA EDGAR CORRESPONDENCE
Division of Corporate Finance
Office of Trade and Services
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Attention:
Nicholas Nalbantian
Dietrich King
Re:
Haoxi Health Technology Limited
Registration Statement on Form F-1
(File No. 333-280174)
REQUEST FOR ACCELERATION OF EFFECTIVENESS
Ladies and Gentlemen:
In accordance with Rule 461
of the General Rules and Regulations under the Securities Act of 1933, as amended, EF Hutton LLC, as representative of the underwriters
(the “Representative”), hereby requests acceleration of the effective date of the above-referenced Registration Statement
so that it will become effective at 5:30 p.m., Eastern Time, on September 18, 2024, or as soon thereafter as practicable.
Pursuant to Rule 460 under
the Act, we wish to advise you that the Representative has distributed as many copies of the preliminary prospectus to underwriters, dealers,
institutions and others as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned confirms
that it has complied with and will continue to comply with, and it has been informed or will be informed by participating dealers that
they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended, in connection
with the above-referenced issue.
EF Hutton LLC
By:
/s/ Stephanie Hu
Name:
Stephanie Hu
Title:
Co-Head of Investment Banking